An Integrated Proteomic Approach to Identifying Circulating Biomarkers in High-Risk Neuroblastoma and Their Potential in Relapse Monitoring
Proteomics - Clinical Applications - Germany
doi 10.1002/prca.201000089
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 7, 2011
Authors
Publisher
Wiley